Q. BIRSA-101, recently in the news, is related to which of the following?

[A] A gene-editing technology for improving crop varieties

[B] A biotechnology scheme for tribal livelihood improvement

[C] A genome sequencing programme for rare diseases

[D] A CRISPR-based gene therapy for Sickle Cell Disease

Answer: D
Notes:

Explanation: BIRSA-101 is India’s first indigenous CRISPR-based gene therapy specifically developed to treat Sickle Cell Disease (SCD). It is named after tribal leader Birsa Munda, as SCD is highly prevalent among tribal populations. The therapy has been developed by the CSIR-Institute of Genomics and Integrative Biology (IGIB).

Source- PIB

Blog
Academy
Community